Sankey It
Loading...
Johnson & Johnson FY2021 income statement | Sankey It
Sankey It · JNJ
Johnson & Johnson FY2021 income statement
USD · fiscal year ended 2022-01-02
FY2025
FY2024
FY2023
FY2022
FY2021
Quarterly
Annual
comfortable
compact
Hide amounts
Export
Fullscreen
Johnson & Johnson FY2021 income statement
Flow diagram with 11 nodes and 10 flows for Johnson & Johnson FY2021 income statement. Values: Pharmaceutical US$52.1B, Medical Devices US$27.1B, Consumer US$14.6B, Revenue US$78.7B, Cost of Revenue US$23.4B, Gross Profit US$55.3B, Operating Expenses US$34.4B, Operating Income US$20.9B, Other Expense US$1.8B, Tax US$1.4B, Net Income US$20.9B.
Pharmaceutical
US$52.1B
56% of revenue
Medical Devices
US$27.1B
29% of revenue
Consumer
US$14.6B
16% of revenue
Revenue
US$78.7B
Cost of Revenue
(US$23.4B)
25% of revenue
Gross Profit
US$55.3B
59% margin
Operating Expenses
(US$34.4B)
37% of revenue
Operating Income
US$20.9B
22% margin
Other Expense
(US$1.8B)
2% of revenue
Tax
(US$1.4B)
1% of revenue
Net Income
US$20.9B
22% margin
Net / profit
Inputs
Tax / cost
Copy link
Share on X
Open full screen